Decheng Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5

- Investments
-
97
- Portfolio
-
29
- Exits
-
40

Decheng Capital General Information
Company Description
Founded in 2012, Decheng Capital is a venture capital firm based in Menlo Park, California. The firm seeks to invest in early-stage life science companies and growth stage healthcare companies. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.decheng.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 3000 Sand Hill Road
- Building 2, Suite 110
- Menlo Park, CA 94025
- United States
Decheng Capital Investments (97)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Ottimo Pharma | 12-Dec-2024 | Later Stage VC | Drug Discovery | Startup | ||
Aclaris Therapeutics | 18-Nov-2024 | Drug Discovery | Generating Revenue | |||
Nalu Medical | 09-Oct-2024 | Therapeutic Devices | Generating Revenue | |||
Adela | 27-Jul-2024 | Diagnostic Equipment | Generating Revenue | |||
Aardvark Therapeutics | 09-May-2024 | Drug Discovery | Generating Revenue/Not Profitable | |||
Upstream Bio | 05-Apr-2024 | Drug Discovery | Generating Revenue/Not Profitable | |||
ImmPACT Bio | 01-Apr-2024 | Drug Discovery | Generating Revenue | |||
FireFly Bio | 15-Feb-2024 | Drug Discovery | Generating Revenue | |||
ConjugateBio | 01-Dec-2023 | Early Stage VC | Biotechnology | Stealth | ||
YolTech Therapeutics | 21-Sep-2023 | Early Stage VC | Drug Discovery | Generating Revenue |
Decheng Capital Exits (40)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
ImmPACT Bio | 31-Oct-2024 | Merger/Acquisition | |
Upstream Bio | 11-Oct-2024 | ||
AnHeart Therapeutics | 09-Apr-2024 | ||
Xtremity | 28-Mar-2024 | ||
CG Oncology | 25-Jan-2024 | ||
Alpine Immune Sciences | 06-Nov-2023 | ||
Mindstrong | 03-Jun-2023 | ||
Acelyrin | 05-May-2023 | ||
Apexigen | 01-Aug-2022 | Reverse Merger | |
GenapSys | 14-Jul-2022 | Bankruptcy: Admin/Reorg |
Decheng Capital Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
Decheng Capital Investments by Industry, Year, and Region
Decheng Capital Co-Investors (159)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
OrbiMed | 6 |
![]() |
![]() |
||
Foresite Capital |
![]() |
![]() |
|||
Surveyor Capital |
![]() |
![]() |
|||
HBM Healthcare Investments |
![]() |
![]() |
|||
RTW Investments |
![]() |
![]() |
Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
Decheng Capital China Management | Shanghai, China | 2012 |
Decheng Capital FAQs
-
What is Decheng Capital?
Founded in 2012, Decheng Capital is a venture capital firm based in Menlo Park, California.
-
When was Decheng Capital founded?
Decheng Capital was founded in 2012.
-
Where is Decheng Capital headquartered?
Decheng Capital is headquartered in Menlo Park, CA.
-
What is Decheng Capital's total asset value?
Decheng Capital has around
in total assets under management. -
How many investments has Decheng Capital made?
Decheng Capital has made 97 investments.
-
What has Decheng Capital invested in?
Decheng Capital has made numerous investments in companies like Ottimo Pharma, Aclaris Therapeutics, and Nalu Medical within the Drug Discovery and Therapeutic Devices industries.
-
What has Decheng Capital invested in recently?
Decheng Capital's latest investment was on 12-Dec-2024 in Ottimo Pharma, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »